EGFR and lung carcinoma: Notably, an international multicenter study with a large cohort of cases developed a DL model based on the entire lung, which achieved an AUC of 0.812 in predicting EGFR status in lung cancer and successfully stratified progression‐free survival in patients treated with EGFR‐TKI.